Humacyte, Inc. (HUMA) scores 25 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is 0.05, representing a 92% premium to fair value. Quantitative score: 26/100. Qualitative score: 70/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.